Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Prostatic Neoplasms 6Breast Neoplasms 3Vaginitis 1Urologic Neoplasms 1Urologic Diseases 1Sexuality 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Hypogonadism 1Dyspareunia 1Castration-Resistant Prostate Carcinoma 1

Interventions

Counseling 4Psychiatric Rehabilitation 3Sildenafil Citrate 2methyl N-acetylsibirosaminide 1exemestane 1black cohosh root extract 1Testosterone Propionate 1Testosterone 1Tamoxifen 1Surveys and Questionnaires 1Sexual Health 1Radiotherapy 1Prostatectomy 1Pilocarpine 1Phentolamine 1Papaverine 1Oncology Nursing 1Educational Status 1Diet Therapy 1Aromatase Inhibitors 1Arginine 1ArginMax 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sexuality × Testosterone Propionate × Clear all
NCT00075855 2016-07-13

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Alliance for Clinical Trials in Oncology

Phase 3 Completed
150 enrolled
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡